Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Nexstim

9.22 EUR-0.43 %7.10, 17.29
5,687 following

NXTMH

First North Finland

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor views
Compare
-0.43 %
-14.63 %
-5.92 %
+1.77 %
-35.07 %
-30.15 %
+236.50 %
+122.17 %
-98.48 %

Nexstim operates in medical technology. The company has developed a non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with 3D navigation providing targeting of the TMS to the specific area of the brain. The technology is aimed for the treatment of major depression and chronic neuropathic pain. The company was founded in 2000 and has its headquarters in Helsinki.

Read more
Market cap
74.45M EUR
Turnover
37.55K EUR
P/E (adj.) (26e)
112.67
EV/EBIT (adj.) (26e)
55.91
P/B (26e)
7.54
EV/S (26e)
5.24
Dividend yield-% (26e)
-
Coverage
Recommendation
Accumulate
Target price
11.00 EUR
Updated
16.08.2026
Disclaimer
Antti Siltanen
Antti Siltanen

Analyst

Latest research

Latest analysis report

Released: 17.08.2026

Latest extensive report

Released: 26.06.2025

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Press releases
3rd party
ShowingAll content types

Forum discussions
Se olisi vähän harhaanjohtavaa, sillä kaikkia kauppoja ei ole myöskään tiedotettu. Syyskuun loppuun mennessä oli tänä vuonna tiedotettu 36 kauppaa ja viime vuonna syyskuun loppuun mennessä oli tiedotettu 23 kauppaa.
9 hours ago
by Kyhnykeisari
11
Onkohan kellään mahdollisuutta kertoa kohokohtia tästä Oxfordin julkaisusta: https://academic.oup.com/brain/advance-article-abstract/doi/10.1093/brain/awag329/8840835?redirectedFrom=fulltext&login=false edit: Lisätään tähän Australian alz-tutkimuksesta heidän kommenttejaan, hyvält...
yesterday
by AccionHombre
7
Kössi obviously has no insider information whatsoever. And the owners have only sold a marginal amount. Let’s keep a cool head now.
10/2/2026, 5:43 PM
by MagnificRat
7
It’s frustrating when there are no deals announced and the share price keeps dropping. Maybe this could help: terveystalo.com Magneettistimulaatio eli rTMS-hoito | Terveystalo Magneettistimulaatiota voidaan käyttää masennuksen ja pitkittyneen hermovauriokivun hoitoon. Magneettistimulaatio...
yesterday
by Tojopa
6
Niin, toisaalta kun osa kaupoista ilmoitellaan 10kpl nippuina, niitä ei tule ihan joka viikko. Tässä on kuitenkin yli 2kk aikaa tulla seuraava vielä tälle vuodelle. Odottavan aika on pitkä vai miten se menikään. Joka tapauksessa se seuraava tai seuraavat suuremmat niput määrittelev...
9 hours ago
by Informaatio
4
Either way works fine for me. I have that much confidence in Sinaptica
10/2/2026, 10:02 PM
by MagnificRat
4
Perhaps not the kind of press release people have been waiting for. Still, maybe this should be seen as a sign that at least there’s no major negative news ahead, if insiders are allowed to sell.. Inderes Nexstim Oyj: Johdon liiketoimet, Laine - Inderes Yhtiötiedote, Helsinki, 2....
10/2/2026, 11:14 AM
by Tojopa
4
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
25.2
2027

Annual report '26

Regulatory press release02.10.2026, 13.00

Nexstim Plc: Managers’ Transactions, Laine

Nexstim
Press release04.09.2026, 08.00

European University Hospital Orders Nexstim NBS 6 System

Nexstim
Press release03.09.2026, 08.00

Nordic Private Clinic Expands Use with Additional NBS 6 System

Nexstim

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Third party research02.09.2026, 08.11

Nexstim: Stimulating growth with surgical accuracy; INITIATE with BUY - NuWays AG Research

Nexstim is a Finnish MedTech company and a global leader in navigated transcranial magneticstimulation (nTMS) technology. With nTMS, Nexstim helps (i) surgeons preserve patients' motor and speech cortices and (ii) clinicians treat neurological and psychiatric...

Nexstim
Press release02.09.2026, 08.00

US University Customer Purchases Nexstim NBS 6 for Research Purposes

Nexstim
Press release01.09.2026, 08.00

European Hospital Orders Nexstim NBS 6 System

Nexstim
Press release21.08.2026, 08.00

Nexstim Receives NBS 6 System Order for a European hospital and existing Nexstim customer

Nexstim
Regulatory press release20.08.2026, 12.00

Nexstim Plc: Managers’ Transactions, Weckroth

Nexstim
Press release19.08.2026, 08.00

Nexstim Receives NBS 6 Therapy System Order from New US Customer

Nexstim
Nexstim H1'26: Brainlab potential to be weighed later this year
Research17.08.2026, 09.09 by
Antti Siltanen

Nexstim H1'26: Brainlab potential to be weighed later this year

Concrete evidence of the Brainlab collaboration's potential will be available during the rest of the year.

Nexstim
Regulatory press release14.08.2026, 08.00

NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 – JUNE 30, 2026 (UNAUDITED)

Nexstim
Press release11.08.2026, 08.00

Notice of Nexstim Plc’s Half-Year Report H1 2026

Nexstim
Nexstim H1'26 preview: Our expectations for the beginning of the year are moderate
Analyst Comment11.08.2026, 08.25 by
Antti Siltanen

Nexstim H1'26 preview: Our expectations for the beginning of the year are moderate

We expect the dip in recurring revenue to have weighed on earnings.

Nexstim
Press release31.07.2026, 12.00

Finnish Private Clinic Group Orders Additional Nexstim NBS 6 System

Nexstim
Regulatory press release20.07.2026, 12.00

Nexstim Plc: Disclosure of major holdings under Chapter 9, Section 10 of the Finnish Securities Markets Act

Nexstim
Press release17.07.2026, 08.00

Delve Psychiatry Upgrades to Nexstim's Latest NBS 6 Platform

Nexstim
Press release15.07.2026, 08.00

Nexstim Receives NBS 6 Therapy System Order from a Neurology Clinic in the United States

Nexstim
Nexstim received another order for ten NBS 6 systems
Analyst Comment15.07.2026, 08.01 by
Frans-Mikael Rostedt

Nexstim received another order for ten NBS 6 systems

The second order for ten systems within a month indicates the rapid scaling of the distribution partnership.

Nexstim
Press release14.07.2026, 08.00

Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor

Nexstim
Press release10.07.2026, 08.00

Nexstim Receives Expanded Health Canada Approval for NBS 6 Diagnostics and Pain Applications

Nexstim